Cleanse
Cleanse, licence 80085309: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Zinzino AB
- NPN or DIN-HM
- 80085309
- Status
- Active licence
- Licence date
- 16 May 2018
- Revision date
- 19 June 2025
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Juniperus communis L.: L'étiquetage doit comporter un avertissement recommandant de ne pas utiliser en cas d'insuffisance rénale et un avertissement recommandant de ne pas utiliser de manière prolongée (maximum 6 semaines)
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Senna alexandrina Mill.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans, aux femmes enceintes et allaitantes et une mention déconseillant l'usage prolongé.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Frangula purshiana Cooper: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans, aux femmes enceintes et allaitantes ainsi qu'une mention déconseillant l'usage prolongé.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Juniperus communis Source : Fruit | 49.5 mg | Not calculated |
| Senna alexandrina Source : Feuille | 0.88 mg | Not calculated |
| Elymus repens subsp. repens Source : Rhizome | 49.5 mg | Not calculated |
| Agathosma betulina Source : Feuille | 49.5 mg | Not calculated |
| Arctostaphylos uva-ursi Source : Feuille | 49.5 mg | Not calculated |
| Hydrangea arborescens Source : Racine | 49.5 mg | Not calculated |
| Zea mays Source : Styles | 49.5 mg | Not calculated |
| Frangula purshiana Source : Écorce âgée Extract : Matériel brut sec Extraction ratio : 8:1 Dry plant equivalent : 200 mg Potency : 20.0 % Hydroxyanthracene derivatives | 25.0 mg | Not calculated |
| Senna alexandrina Source : Feuille Potency : 16.0 % Hydroxyanthracene derivatives | 25.0 mg | Not calculated |
| Bacillus coagulans Source : Cellule entière | 6.0 mg | Not calculated |
| Senna alexandrina Source : Feuille Potency : 8.0 % Hydroxyanthracene derivatives | 0.07 mg | Not calculated |
| Tamarindus indica Source : Fruit | 0.01 mg | Not calculated |
| Ficus carica Source : Fruit | 0.003 mg | Not calculated |
| Rheum undulatum Source : Racine Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 104 mg | 26.0 mg | Not calculated |
Non-medicinal ingredients
Bleu FD&C n° 2, Maltodextrine, Fibre de Pyrus malus (Pomme), Fruit de Phoenix Dactylifera (Date), Jaune FD&C No. 5, Croscarmellose de sodium, NA, Hypromellose, Stéarate de magnésium, Cellulose microcristalline, Prune dénoyautée, Talc, Acide stéarique, Dioxyde de silicium, Poly(dextrose), Jaune FD&C n° 6, Fibre de cosse d'avoine, Poudre de caroube, Dioxyde de titane, PVP, Phosphate dicalcique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 2.0 Comprimé | 1.0 Tous les jours |
Uses authorised in Canada
(Traditionally used in Herbal Medicine as a) stimulant laxative. (Used in Herbal Medicine for the) short-term relief of occasional constipation. (Used in Herbal Medicine to) promote(s) bowel movement (by direct action on the large intestine).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use if you are taking other medications or health products which may aggravate electrolyte imbalance. Consult a health care practitioner prior to use if you are taking cardiac medications such as cardiac glycosides or antiarrhythmic medications. Consult a health care practitioner prior to use if you have faecal impaction or symptoms such as abdominal pain, nausea, vomiting or fever. Reduce dose or discontinue use if you experience abdominal pain, cramps, spasms and/or diarrhoea. If symptoms of digestive upset occurs, worsen or persist beyond three days, discontinue use and consult a health care practitioner. If you have painful urination (dysuria), spasms, or blood in urine, consult a health care practitioner prior to use.
- Contre-indications
Do not use if you are pregnant or breastfeeding. Do not use if you have abnormal constrictions of the gastrointestinal tract, potential or existing intestinal blockage, atonic bowel, appendicitis, inflammatory colon disease such as Crohn's disease or ulcerative colitis, abdominal pain of unknown origin, undiagnosed rectal bleeding, severe dehydration with depleted water or electrolytes or diarrhoea. Do not use if you have a kidney disorder. Do not take with highly acidic foods (e.g. citrus fruits and juice) or medications which may acidify urine. Do not use this product if you have an immune-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroids treatment). If you have heart disease, high or low blood pressure, liver disorder, diabetes or edema (swelling of hands, face and feet) or are taking products containing diuretics, corticosteroids or licorice, do not use. Stop use and seek medical attention immediate if you experience dizziness, confusion, muscle weakness or pain, abnormal heart beat and/or difficulty breathing.
- Effets indésirables connus
Hypersensitivity is known to occur, in which case, discontinue use.
Source
Official Health Canada record, licence 80085309
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.